Survival analysis of patients with T1LG bladder cancer treated with BCG immunotherapy

被引：0

作者：

Krajewski, W. ^{[1
]}

Subiela, J. D. ^{[2
]}

Piszczek, R. ^{[3
]}

Del Giudice, F. ^{[4
]}

Nowak, L. ^{[1
]}

Chorbinska, J. ^{[1
]}

Moschini, M. ^{[5
]}

Masson-Lecomte, A. ^{[6
]}

Bebane, S. ^{[6
]}

Cimadamore, A. ^{[7
]}

Grobet-Jeandin, E. ^{[8
]}

Roupret, M. ^{[8
]}

D'andrea, D. ^{[9
]}

Mastroianni, R. ^{[10
]}

Gutierrez Hidalgo, B. ^{[11
]}

Gomez Rivas, J. ^{[12
]}

Mori, K. ^{[13
]}

Soria, F. ^{[14
]}

Laukhtina, E. ^{[9
]}

Carrion, D. M. ^{[15
]}

Akand, M. ^{[16
]}

Pradere, B. ^{[17
]}

Malkiewicz, B. ^{[1
]}

Szydelko, T. ^{[1
]}

机构：

[1] Uniwersytet Medyczny Piastow Slaskich Wroclawiu, Dept Minimally Invas & Robot Urol, Wroclaw, Poland

[2] Univ Alcala, Hosp Univ Ramon & Cajal, Dept Urol, Madrid, Spain

[3] Lower Silesian Specialist Hosp, Dept Urol & Oncol Urol, Wroclaw, Poland

[4] Sapienza Univ Rome, Policlin Umberto I, Dept Urol, Rome, Italy

[5] Univ Vita Salute San Raffaele, Urol Res Inst, Div Expt Oncol, Dept Urol, Milan, Italy

[6] Nord Univ Paris, St Louis Hosp, APHP, Dept Urol, Paris, France

[7] Polytechn Univ Marche Reg, United Hosp, Sect Pathol Anat, Ancona, Italy

[8] APHP, Dept Predict Onco Urol, Paris, France

[9] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria

[10] IRCCS Regina Elena Natl Canc Inst, Dept Urol, Rome, Italy

[11] Jikei Univ, Dept Urol, Sch Med, Madrid, Spain

[12] Hosp Clin San Carlos, Dept Urol, Madrid, Spain

[13] Jikei Univ, Sch Med, Dept Urol, Tokyo 1058461, Japan

[14] Univ Torino, Molinette Hosp, Sch Med, Dept Urol, Turin, Italy

[15] Torrejon Univ Hosp, Dept Urol, Madrid, Spain

[16] Univ Hosp Leuven, Dept Urol, Leuven, Belgium

[17] CHU Tours, Dept Urol, Tours, France

来源：

EUROPEAN UROLOGY | 2023年 / 83卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0714

引用

页数：2

共 50 条

[1] BCG in Bladder Cancer Immunotherapy
Jiang, Song
Redelman-Sidi, Gil
CANCERS, 2022, 14 (13)
[2] Gene expression profiles analysis of patients with bladder cancer treated with BCG
Saint, F
Sanchez-Carbayo, M
de Medina, SGD
Lozano, JJ
Zhao, H
Socci, N
Viale, A
Ortiz, A
Chopin, D
Cordon-Cardo, C
JOURNAL OF UROLOGY, 2003, 169 (04): : 186 - 186
[3] BCG immunotherapy for superficial bladder cancer
Lane, T
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2001, 94 (06) : 316 - 316
[4] BCG immunotherapy for superficial bladder cancer
Richard, C
Lockyer, W
Gillatt, DA
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2001, 94 (03) : 119 - 123
[5] Review of BCG immunotherapy for bladder cancer
Liatsos, George D.
Mariolis, Ilias
Hadziyannis, Emilia
Bamias, Aristotelis
Vassilopoulos, Dimitrios
CLINICAL MICROBIOLOGY REVIEWS, 2025, 38 (01)
[6] Bladder Cancer Immunotherapy: BCG and Beyond
Askeland, Eric J.
Newton, Mark R.
O'Donnell, Michael A.
Luo, Yi
ADVANCES IN UROLOGY, 2012, 2012
[7] T1G3 BLADDER CANCER TREATED CONSERVATIVELY WITH BCG OR WITH NO BCG: LONG -TERM FOLLOW UP IN 249 PATIENTS
Wehbi, Elias
Bostrom, Peter
Alkhateeb, Sultan
Van Rhijn, Bas
Hanna, Sally
Fleshner, Neil
Finelli, Antonio
Jewett, Michael
Zlotta, Alexandre
JOURNAL OF UROLOGY, 2010, 183 (04): : E566 - E566
[8] Impact of Smoking Intensity on Outcomes of Patients with Non Muscle Invasive Bladder Cancer Treated by BCG Immunotherapy
Ajili, Faouzia
Kourda, Nadia
Karay, Salma
Darouiche, Amine
Chebil, Mohamed
Boubaker, Samir
ULTRASTRUCTURAL PATHOLOGY, 2013, 37 (04) : 273 - 277
[9] ADJUVANT LOCAL BCG-IMMUNOTHERAPY IN PATIENTS WITH UROTHEL CANCER OF THE BLADDER
FLAMM, J
GROF, F
WIENER MEDIZINISCHE WOCHENSCHRIFT, 1981, 131 (20) : 501 - 506
[10] Complications of Intravesical BCG Immunotherapy for Bladder Cancer
Green, Daniel B.
Kawashima, Akira
Menias, Christine O.
Tanaka, Takashi
Redelman-Sidi, Gil
Bhalla, Sanjeev
Shah, Rakesh
King, Bernard F.
RADIOGRAPHICS, 2019, 39 (01) : 80 - 94

← 1 2 3 4 5 →